|
Market Closed -
OTC Markets
12:00:15 2026-05-14 pm EDT
|
5-day change | 1st Jan Change | ||
| 0.000100 USD | +9,900.00% |
|
-.--% | +9,900.00% |
| 18-12-11 | Alternate Health Announces Executive Changes | CI |
| 18-02-01 | Alternate Health Corp Announces Executive Changes | CI |
| Market Cap | 5.7M 4.92M 4.61M 4.21M 7.92M 543M 7.96M 54.65M 21.33M 275M 21.39M 20.92M 912M | P/E 2017 |
-3.04x | P/E 2018 | -0.76x |
|---|---|---|---|---|---|
| Enterprise Value | 4.92M 4.25M 3.99M 3.64M 6.85M 470M 6.88M 47.24M 18.44M 238M 18.49M 18.09M 788M | EV / Sales 2017 |
6.25x | EV / Sales 2018 | 37.9x |
| Free-Float |
100% | Yield 2017 * |
-
| Yield 2018 | - |
| 1 day | +9,900.00% | ||
| 6 months | +9,900.00% | ||
| Current year | +9,900.00% |
| Current year | 0 |  | 0 |
| 1 year | 0 | | 0 |
| 3 years | 0 | | 0 |
| 5 years | 0 | | 0.75 |
| 10 years | 0 | | 6.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
Howard Mann
CEO | Chief Executive Officer | - | 2018-12-10 |
| Director | Title | Age | Since |
|---|---|---|---|
James E. Tykoliz
BRD | Director/Board Member | - | 2015-04-15 |
| Chairman | - | 2017-04-04 | |
Howard Mann
BRD | Director/Board Member | - | 2018-12-10 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 6/12/20 | Sell | Chairman | 8,727,896 | 11.2061% | ||
| 6/12/20 | Other | Chairman | 0 | 0% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +9,900.00% | -.--% | +9,900.00% | -.--% | 9.15K | |
| +0.02% | +1.36% | -12.54% | -5.59% | 13.26B | |
| +0.53% | +2.99% | -32.15% | -56.36% | 4.99B | |
| +0.27% | +1.59% | -3.46% | +0.53% | 4.66B | |
| -0.43% | -1.64% | -0.25% | -29.65% | 4.02B | |
| +0.08% | +3.06% | -17.20% | +7.02% | 3.59B | |
| -0.67% | +2.71% | -2.91% | -3.69% | 3.43B | |
| +0.47% | -0.53% | -10.57% | +8.77% | 3.31B | |
| -2.19% | -2.26% | -24.23% | -12.67% | 2.38B | |
| +0.74% | +2.97% | -26.68% | -9.75% | 1.72B | |
| Average | +989.88% | +1.71% | +977.00% | -10.14% | 4.14B | |
| Weighted average by Cap. | -0.04% | +1.73% | -13.40% | -11.54% |
| 2017 | 2018 | |
|---|---|---|
| Net sales | 13.25M 11.44M 10.73M 9.79M 18.43M 1.26B 18.51M 127M 49.64M 639M 49.76M 48.68M 2.12B | 577K 498K 467K 426K 802K 55.05M 806K 5.54M 2.16M 27.84M 2.17M 2.12M 92.37M |
| Net income | -26.13M -22.56M -21.15M -19.31M -36.33M -2.49B -36.51M -251M -97.87M -1.26B -98.12M -95.98M -4.18B | -23.99M -20.71M -19.41M -17.72M -33.35M -2.29B -33.51M -230M -89.83M -1.16B -90.06M -88.1M -3.84B |
| Net Debt | -893K -771K -722K -659K -1.24M -85.13M -1.25M -8.56M -3.34M -43.05M -3.35M -3.28M -143M | -773K -667K -625K -571K -1.07M -73.69M -1.08M -7.41M -2.89M -37.26M -2.9M -2.84M -124M |
Employees
-
Sector
Pharmaceuticals
- Stock Market
- Stocks
- AHGIF Stock
Select your edition
All financial news and data tailored to specific country editions
